scholarly article | Q13442814 |
P2093 | author name string | G H Cohen | |
R J Eisenberg | |||
L A Lasky | |||
T C Merigan | |||
P W Berman | |||
C J Heilman | |||
C P Cerini | |||
J W Torseth | |||
S Kerwar | |||
P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer | Q33912259 | ||
Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2 | Q36333640 | ||
Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. | Q36431330 | ||
Type-Common CP-1 Antigen of Herpes Simplex Virus Is Associated with a 59,000-Molecular-Weight Envelope Glycoprotein | Q36522265 | ||
Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody. | Q36591131 | ||
Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge | Q36855019 | ||
Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting | Q36883752 | ||
Localization of epitopes of herpes simplex virus type 1 glycoprotein D | Q36898378 | ||
Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody | Q36939761 | ||
Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. | Q37099580 | ||
Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells | Q37500512 | ||
Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon | Q37564045 | ||
Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D. | Q37688772 | ||
Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to Herpes simplex antigen | Q39317945 | ||
Infections with herpes simplex viruses (1). | Q39499816 | ||
Quantification of antigen-reactive cells among human T lymphocytes | Q39505778 | ||
Immunochemistry of Herpes Simplex Virus Glycoproteins | Q40098791 | ||
The pathogenesis of acute, latent and recurrent herpes simplex virus infections | Q40104231 | ||
T cell growth factor: parameters of production and a quantitative microassay for activity | Q40680131 | ||
Inhibition of herpes simplex virus type 1-induced interferon synthesis by monoclonal antibodies against viral glycoprotein D and by lysosomotropic drugs | Q41916428 | ||
Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. | Q42079503 | ||
Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection | Q42128912 | ||
A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans | Q44554983 | ||
DNA Sequence Analysis of the Type-Common Glycoprotein-D Genes of Herpes Simplex Virus Types 1 and 2 | Q44757003 | ||
Herpes Simplex Virus Type-1 Glycoprotein D Gene: Nucleotide Sequence and Expression inEscherichia coli | Q45799667 | ||
Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. | Q45804968 | ||
Immune-specific interferon production by peripheral blood mononuclear leukocytes from patients with primary and recurrent oro-labial herpes simplex virus infections | Q45838252 | ||
Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. | Q45838945 | ||
The T cell response to the glycoprotein D of the herpes simplex virus: the significance of antigen conformation | Q45848696 | ||
Significance of local gamma interferon in recurrent herpes simplex infection | Q46166940 | ||
Lymphocyte interferon production and transformation after Herpes simplex infections in humans. | Q53778821 | ||
Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis | Q70459367 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Herpes simplex virus type 1 | Q655331 |
P304 | page(s) | 1532-1539 | |
P577 | publication date | 1987-05-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses | |
P478 | volume | 61 |
Q36759693 | An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs |
Q36633084 | Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. |
Q30957753 | CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins |
Q36920514 | Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells |
Q36827612 | Fine mapping of antigenic site II of herpes simplex virus glycoprotein D |
Q33668447 | Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice |
Q41977321 | Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations |
Q46938367 | Native HSV Glycoprotein D Subunit Vaccine: Analysis ofin VitroT-Cell Activation and Antigen Presentation* |
Q33963713 | Recent progress in herpes simplex virus immunobiology and vaccine research |
Q39580355 | Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions |
Q43824158 | Stable transgene expression from HSV amplicon vectors in the brain: potential involvement of immunoregulatory signals |